Lanthanides-Substituted Hydroxyapatite for Biomedical Applications
International Journal of Molecular Sciences · 08.02.2023 · 24 (4) · 3446
DOI: 10.3390/ijms24043446 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.02.2023. Verfasst von María Del Carmen De Lama-Odría und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, EEBE, Av. Eduard Maristany 10-14, 08019 Barcelona, Spain. Hauptthemen laut MEDLINE: Lanthanoid Series Elements, Nanoparticles. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Economy and Competitiveness, Generalitat de Catalunya.
Abstract (Originalsprache)
Lately, there has been an increasing demand for materials that could improve tissue regenerative therapies and provide antimicrobial effects. Similarly, there is a growing need to develop or modify biomaterials for the diagnosis and treatment of different pathologies. In this scenario, hydroxyapatite (HAp) appears as a bioceramic with extended functionalities. Nevertheless, there are certain disadvantages related to the mechanical properties and lack of antimicrobial capacity. To circumvent them, the doping of HAp with a variety of cationic ions is emerging as a good alterative due to the different biological roles of each ion. Among many elements, lanthanides are understudied despite their great potential in the biomedical field. For this reason, the present review focuses on the biological benefits of lanthanides and how their incorporation into HAp can alter its morphology and physical properties. A comprehensive section of the applications of lanthanides-substituted HAp nanoparticles (HAp NPs) is presented to unveil the potential biomedical uses of these systems. Finally, the need to study the tolerable and non-toxic percentages of substitution with these elements is highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, EEBE, Av. Eduard Maristany 10-14, 08019 Barcelona, Spain.
- Barcelona Research Center in Multiscale Science and Engineering, Universitat Politècnica de Catalunya, Campus Diagonal-Besòs, Av. Eduard Maristany 10-14, 08019 Barcelona, Spain.
- Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Carrer Baldiri i Reixac 11-15, 08028 Barcelona, Spain.
ORCID-Profile: Luis J Del Valle, Jordi Puiggalí
Förderung
- Spanish Ministry of Economy and Competitiveness
- Generalitat de Catalunya
Zitieren
APA
De Lama-Odría, M. D. C., Valle, L. J. D., & Puiggalí, J. (2023). Lanthanides-Substituted Hydroxyapatite for Biomedical Applications. International Journal of Molecular Sciences, 24(4), 3446. https://doi.org/10.3390/ijms24043446
Vancouver
De Lama-Odría MDC, Valle LJD, Puiggalí J. Lanthanides-Substituted Hydroxyapatite for Biomedical Applications. International Journal of Molecular Sciences. 2023;24(4):3446. doi:10.3390/ijms24043446
BibTeX
@article{DeLamaOdra2023,
author = {De Lama-Odría, María Del Carmen and Valle, Luis J Del and Puiggalí, Jordi},
title = {Lanthanides-Substituted Hydroxyapatite for Biomedical Applications},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3446},
doi = {10.3390/ijms24043446}
}
EUVIMED